Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 1.1M | 272,669 | 255,833 | 368,433 | 251,163 | -- |
| General And Administrative Expense | 1.1M | 245,415 | 251,933 | 368,433 | 249,458 | -- |
| Research And Development | 84,294 | 152,814 | -- | -- | -- | 0.00 |
| Other Operating Expenses | -12,817 | 71,857 | 64,350 | 225,791 | 619,067 | -- |
| Operating Expense | 1.2M | 497,340 | 320,183 | 594,224 | 895,792 | -- |
| Operating Income | -1.2M | -497,340 | -320,183 | -594,224 | -895,792 | -- |
| EBIT | -1.2M | -497,340 | -320,183 | -594,224 | -895,792 | -- |
| Interest Income | 139.00 | 0.00 | 0.00 | 0.00 | 28,304 | -- |
| Interest Income Non Operating | 139.00 | 0.00 | 0.00 | 0.00 | 28,304 | -- |
| Net Interest Income | 139.00 | 0.00 | 0.00 | 0.00 | 28,304 | -- |
| Other Income Expense | 15,468 | -- | -- | 31,795 | -165,061 | -- |
| Other Non Operating Income Expenses | 15,468 | -- | -- | 31,795 | 18,134 | -- |
| Special Income Charges | 0.00 | 0.00 | 0.00 | -- | -183,195 | 0.00 |
| Gain On Sale Of Security | -- | -- | -- | -- | 0.00 | -- |
| Pretax Income | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| Net Income From Continuing Operation Net Minority Interest | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| Net Income Including Noncontrolling Interests | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| Net Income Common Stockholders | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| Net Income | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| EBITDA | -1.2M | -497,340 | -320,183 | -594,224 | -895,792 | -- |
| Normalized EBITDA | -1.2M | -497,340 | -320,183 | -594,224 | -712,597 | -- |
| Basic EPS | -- | -0.01 | 0.00 | -0.01 | -- | -0.01 |
| Diluted EPS | -- | -0.01 | 0.00 | -0.01 | -- | -0.01 |
| Basic Average Shares | -- | 85.6M | 81.0M | 67.7M | -- | 61.4M |
| Diluted Average Shares | -- | 85.6M | 81.0M | 67.7M | -- | 61.4M |
| Total Unusual Items | 0.00 | 0.00 | 0.00 | -- | -183,195 | 0.00 |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.00 | -- | -183,195 | 0.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -1.2M | -497,340 | -320,183 | -562,429 | -849,354 | -- |
| Diluted NI Availto Com Stockholders | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| Gain On Sale Of Ppe | -- | -- | -- | -- | -- | 0.00 |
| Net Income Continuous Operations | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| Net Non Operating Interest Income Expense | 139.00 | 0.00 | 0.00 | 0.00 | 28,304 | -- |
| Other Gand A | 265,844 | 78,841 | 134,261 | 110,769 | 174,936 | -- |
| Other Special Charges | -- | -- | -- | -- | 0.00 | -- |
| Salaries And Wages | 818,230 | 166,574 | 117,672 | 257,664 | 74,522 | -- |
| Selling And Marketing Expense | 48,124 | 27,254 | 3,900 | 0.00 | 1,705 | -- |
| Total Expenses | 1.2M | 497,340 | 320,183 | 594,224 | 895,792 | -- |
| Total Operating Income As Reported | -- | -497,340 | -320,183 | -- | -870,230 | -379,324 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 575,952 | 122,607 | 366,142 | 62,837 | 1,688 | -- |
| Cash Cash Equivalents And Short Term Investments | 575,952 | 122,607 | 366,142 | 62,837 | 1,688 | -- |
| Cash Financial | 575,952 | 122,607 | 366,142 | 62,837 | 1,688 | -- |
| Accounts Receivable | -- | -- | -- | -- | 0.00 | -- |
| Receivables | 64,569 | 25,029 | 22,653 | 107,109 | 59,413 | -- |
| Prepaid Assets | 29,775 | 79,293 | 82,595 | 88,859 | 38,900 | -- |
| Current Assets | 670,296 | 226,929 | 471,390 | 258,805 | 100,001 | -- |
| Net PPE | -- | -- | -- | -- | -- | 38.6M |
| Total Non Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Assets | 670,296 | 226,929 | 471,390 | 258,805 | 100,001 | -- |
| Accounts Payable | 2.1M | 2.1M | 2.2M | 2.3M | 2.2M | -- |
| Payables | 3.5M | 3.6M | 3.6M | 4.6M | 4.5M | -- |
| Payables And Accrued Expenses | 3.5M | 3.6M | 3.6M | 4.6M | 4.5M | -- |
| Current Liabilities | 4.2M | 4.6M | 4.6M | 5.6M | 5.5M | -- |
| Total Non Current Liabilities Net Minority Interest | 87,500 | 87,500 | 87,500 | 87,500 | 87,500 | -- |
| Total Liabilities Net Minority Interest | 4.3M | 4.7M | 4.7M | 5.6M | 5.6M | -- |
| Common Stock | 79.1M | 77.9M | 77.8M | 76.4M | 76.0M | -- |
| Capital Stock | 79.1M | 77.9M | 77.8M | 76.4M | 76.0M | -- |
| Additional Paid In Capital | 21.2M | 20.4M | 20.2M | 20.1M | 19.9M | -- |
| Retained Earnings | -104.3M | -103.0M | -102.5M | -102.2M | -101.7M | -- |
| Gains Losses Not Affecting Retained Earnings | 273,242 | 273,242 | 273,242 | 273,242 | 273,242 | -- |
| Other Equity Adjustments | 273,242 | 273,242 | 273,242 | 273,242 | 273,242 | -- |
| Common Stock Equity | -3.6M | -4.4M | -4.2M | -5.4M | -5.5M | -- |
| Stockholders Equity | -3.6M | -4.4M | -4.2M | -5.4M | -5.5M | -- |
| Total Equity Gross Minority Interest | -3.6M | -4.4M | -4.2M | -5.4M | -5.5M | -- |
| Total Capitalization | -3.6M | -4.4M | -4.2M | -5.4M | -5.5M | -- |
| Net Tangible Assets | -3.6M | -4.4M | -4.2M | -5.4M | -5.5M | -- |
| Tangible Book Value | -3.6M | -4.4M | -4.2M | -5.4M | -5.5M | -- |
| Working Capital | -3.5M | -4.3M | -4.1M | -5.3M | -5.4M | -- |
| Invested Capital | -3.6M | -4.4M | -4.2M | -5.4M | -5.5M | -- |
| Share Issued | 95.7M | 86.3M | 85.2M | 68.5M | 62.5M | -- |
| Ordinary Shares Number | 95.7M | 86.3M | 85.2M | 68.5M | 62.5M | -- |
| Current Deferred Liabilities | 38,262 | 28,730 | 28,730 | 28,730 | 60,525 | -- |
| Current Deferred Taxes Liabilities | 38,262 | 28,730 | 28,730 | 28,730 | 60,525 | -- |
| Current Provisions | 662,975 | 929,397 | 929,397 | 929,397 | 929,397 | -- |
| Duefrom Related Parties Current | 11,334 | 10,560 | 0.00 | 17,718 | 17,718 | -- |
| Dueto Related Parties Current | 1.3M | 1.5M | 1.4M | 2.3M | 2.3M | -- |
| Non Current Deferred Liabilities | 87,500 | 87,500 | 87,500 | 87,500 | 87,500 | -- |
| Non Current Deferred Revenue | 87,500 | 87,500 | 87,500 | 87,500 | 87,500 | -- |
| Non Current Prepaid Assets | -- | -- | -- | -- | 0.00 | 0.00 |
| Other Equity Interest | 77,834 | 46,190 | 46,190 | 46,190 | 50,714 | -- |
| Other Receivables | 10,894 | 10,894 | 10,894 | 10,894 | 10,894 | -- |
| Taxes Receivable | 42,341 | 3,575 | 11,759 | 78,497 | 30,801 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -611,210 | -243,535 | -196,616 | -364,489 | -663,367 | -- |
| Cash Flow From Continuing Operating Activities | -611,210 | -243,535 | -196,616 | -364,489 | -663,367 | -- |
| Stock Based Compensation | 815,933 | 164,248 | 114,800 | 233,100 | 30,398 | -- |
| Change In Working Capital | 73,458 | 89,557 | 8,767 | -3,365 | 254,516 | -- |
| Change In Receivables | -39,540 | -2,376 | 84,456 | -47,696 | 473,757 | -- |
| Change In Payables And Accrued Expense | 63,480 | 88,631 | -81,953 | 94,290 | -316,973 | -- |
| Change In Payable | 63,480 | -- | -- | -- | -- | -- |
| Other Non Cash Items | -15,468 | 0.00 | 0.00 | -31,795 | -98,927 | -- |
| Net PPE Purchase And Sale | -- | -- | -- | -- | -- | 0.00 |
| Sale Of Investment | 0.00 | 0.00 | -- | -- | -85,141 | 0.00 |
| Net Investment Purchase And Sale | 0.00 | 0.00 | -- | -- | -85,141 | 0.00 |
| Investing Cash Flow | 0.00 | 0.00 | -- | -- | 287,522 | 0.00 |
| Cash Flow From Continuing Investing Activities | 0.00 | 0.00 | -- | -- | 287,522 | 0.00 |
| Repayment Of Debt | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 |
| Issuance Of Capital Stock | 1.1M | 0.00 | 515,000 | 452,500 | 0.00 | -- |
| Net Common Stock Issuance | 1.1M | 0.00 | 515,000 | 452,500 | 0.00 | -- |
| Financing Cash Flow | 1.1M | 0.00 | 499,921 | 425,638 | 87,500 | -- |
| Cash Flow From Continuing Financing Activities | 1.1M | 0.00 | 499,921 | 425,638 | 87,500 | -- |
| Changes In Cash | 453,345 | -243,535 | 303,305 | 61,149 | -288,345 | -- |
| Beginning Cash Position | 122,607 | 366,142 | 62,837 | 1,688 | 290,033 | -- |
| End Cash Position | 575,952 | 122,607 | 366,142 | 62,837 | 1,688 | -- |
| Free Cash Flow | -611,210 | -243,535 | -196,616 | -364,489 | -663,367 | -- |
| Change In Account Payable | 63,480 | -- | -- | -- | -- | -- |
| Change In Prepaid Assets | 49,518 | 3,302 | 6,264 | -49,959 | 125,551 | -- |
| Common Stock Issuance | 1.1M | 0.00 | 515,000 | 452,500 | 0.00 | -- |
| Gain Loss On Investment Securities | -- | -- | -- | -- | 0.00 | 0.00 |
| Gain Loss On Sale Of PPE | -- | -- | -- | -- | -- | 0.00 |
| Long Term Debt Payments | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 |
| Net Income From Continuing Operations | -1.2M | -497,340 | -320,183 | -562,429 | -1.0M | -- |
| Net Long Term Debt Issuance | 0.00 | 0.00 | -- | -- | 0.00 | 0.00 |
| Net Other Financing Charges | -57,495 | 0.00 | -15,079 | -26,862 | 87,500 | -- |
| Net Other Investing Changes | -- | -- | -- | -- | -- | -173,962 |
| Operating Gains Losses | -- | -- | -- | -- | 183,195 | 0.00 |
| Proceeds From Stock Option Exercised | -- | -- | -- | -- | 0.00 | 0.00 |
| Sale Of PPE | -- | -- | -- | -- | -- | 0.00 |